Bokus
Mohammed Shahid, James Baker, Gary C. Starling, Jayashree Aiyar - A Guide to Early Drug Discovery, Inbunden

Inbunden, Engelska, 2026

A Guide to Early Drug Discovery

Building Confidence in Drug Candidates

Av Mohammed Shahid, James Baker, Gary C. Starling, Jayashree Aiyar

1726 kr

Kommande

Beskrivning
Modern early drug discovery is transforming in response to global health challenges, medical needs, and emerging technologies. This book provides a comprehensive overview of the current state-of-the-art and practical guidance for navigating the complexities of early drug discovery. Edited by experienced industry professionals, it features expert contributions from scientists committed to advancing more effective medicines. Readers gain extensive coverage of today's landscape and its future evolution, including drug target systems, therapeutic modalities, candidate optimization and safety, translational approaches, and the role of external innovation in driving pharmaceutical productivity. Designed for scientists, researchers, and stakeholders across biotech, pharma, and academia, the book delivers actionable insights while fostering collaboration and understanding across disciplines. Drug discovery is inherently collaborative, and shared learning across specialties increases success. This resource offers future-focused, experience-driven guidance for anyone seeking to contribute to the development of impactful new therapies.
Produktinformation
Utforska kategorier
Mer om författaren

Dr Mohammed Shahid is a pharmacologist and drug discovery scientist with nearly forty years of experience in pharmaceutical R&D at Organon, Schering-Plough, Merck, Orion Pharma, and Pheno Therapeutics. Currently, he is Director of MS4Pharma Ltd, an independent consultancy, and brings deep expertise in application of innovation across different therapeutic areas. Dr James Baker is Head of DMPK at Blueprint Medicines, with over twenty-five years in drug discovery at Merck, Pfizer, Organon, and Schering-Plough. He is a past Chair of the New England Drug Metabolism Discussion Group and serves on the IQ Consortium's Translational ADME Leadership Group. Dr Gary Starling is an immunologist with over thirty years in biopharmaceutical research, focusing on antibody-based therapeutics. He has held senior roles at Bristol Myers Squibb, CuraGen, Abbott, and Merck, and currently serves as Senior Advisor, Oncology Research at Astellas Pharma in California. Dr Jayashree Aiyar is a molecular pharmacologist with over thirty years of experience leading drug discovery programs at AstraZeneca, Merck, Ambrx, and Theravance. She holds a PhD in Immunology from AIIMS, New Delhi, and is currently Chief Scientific Officer, driving R&D strategy and academia-industry collaboration.

Recensioner i media

Select Guide Rating

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.